Although TFBUT was the primary clinical endpoint, the study was powered on TNF- as a biologically relevant surrogate due to limited prior ophthalmic data for GSH-C4
For instance, in June 2024, the Therapeutics Goods Administration (TGA) of Australian announced amendments to the Therapeutics Goods Regulations 1990 (Schedule 5, item 6) under which compounded GLP-1 RA products and medicines will no longer compounded by pharmacists and supplied to patients effective from October 1, 2024
Bernard, A., Carlier, H
Thyroid 27 , 271278 (2017)
[Abstract] Different transmission of MAPK8/FoxO signaling pathway in breast cancer cells (MCF-7, T47D, ZR-75, and MDA-MB-231) and liver cells (LO2) exposed to TAM (Tamoxifen)
This inherent stability makes Retatrutide Powder an ideal choice for pharmaceutical manufacturers who require consistent quality over extended production cycles